Biodyne Co Ltd
KOSDAQ:314930
Balance Sheet
Balance Sheet Decomposition
Biodyne Co Ltd
Biodyne Co Ltd
Balance Sheet
Biodyne Co Ltd
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1 417
|
659
|
2 984
|
9 455
|
10 735
|
9 726
|
4 833
|
|
| Cash |
1
|
0
|
0
|
3
|
3
|
3
|
10
|
|
| Cash Equivalents |
1 416
|
659
|
2 984
|
9 452
|
10 732
|
9 724
|
4 823
|
|
| Short-Term Investments |
0
|
1 158
|
1 000
|
16 007
|
10 000
|
10 000
|
15 880
|
|
| Total Receivables |
1 920
|
1 950
|
1 545
|
1 055
|
605
|
754
|
1 141
|
|
| Accounts Receivables |
1 831
|
1 430
|
994
|
914
|
578
|
614
|
830
|
|
| Other Receivables |
89
|
520
|
550
|
141
|
27
|
141
|
312
|
|
| Inventory |
1 071
|
1 011
|
1 030
|
1 207
|
1 513
|
434
|
437
|
|
| Other Current Assets |
112
|
302
|
132
|
264
|
62
|
220
|
69
|
|
| Total Current Assets |
4 521
|
5 081
|
6 690
|
27 987
|
22 915
|
21 134
|
22 361
|
|
| PP&E Net |
296
|
10 239
|
10 639
|
11 310
|
11 531
|
11 293
|
10 836
|
|
| PP&E Gross |
296
|
10 239
|
10 639
|
11 310
|
11 531
|
11 293
|
10 836
|
|
| Accumulated Depreciation |
1 296
|
1 442
|
689
|
1 090
|
1 783
|
2 409
|
2 984
|
|
| Intangible Assets |
7 533
|
6 787
|
6 064
|
5 355
|
4 895
|
4 114
|
3 346
|
|
| Note Receivable |
213
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
0
|
0
|
5 967
|
7 113
|
7 361
|
|
| Other Long-Term Assets |
350
|
1 144
|
1 851
|
1 170
|
103
|
333
|
444
|
|
| Total Assets |
12 915
N/A
|
23 251
+80%
|
25 245
+9%
|
45 823
+82%
|
45 414
-1%
|
43 986
-3%
|
44 347
+1%
|
|
| Liabilities | ||||||||
| Accounts Payable |
112
|
134
|
69
|
162
|
168
|
59
|
61
|
|
| Accrued Liabilities |
25
|
39
|
36
|
74
|
229
|
226
|
257
|
|
| Short-Term Debt |
6 290
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1 725
|
2 170
|
135
|
11
|
10
|
12
|
12
|
|
| Other Current Liabilities |
4 341
|
7 473
|
5 339
|
7 066
|
846
|
306
|
818
|
|
| Total Current Liabilities |
12 493
|
9 815
|
5 578
|
7 313
|
1 254
|
604
|
1 148
|
|
| Long-Term Debt |
0
|
6 860
|
8 924
|
12
|
2
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3 739
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
12 493
N/A
|
16 675
+33%
|
18 242
+9%
|
7 324
-60%
|
1 255
-83%
|
604
-52%
|
1 148
+90%
|
|
| Equity | ||||||||
| Common Stock |
378
|
448
|
2 444
|
3 084
|
3 084
|
3 091
|
14 882
|
|
| Retained Earnings |
2 752
|
4 778
|
9 233
|
20 090
|
14 478
|
15 470
|
15 459
|
|
| Additional Paid In Capital |
2 797
|
10 906
|
13 754
|
65 713
|
65 935
|
66 278
|
54 294
|
|
| Treasury Stock |
0
|
0
|
0
|
10 517
|
10 517
|
10 517
|
10 517
|
|
| Other Equity |
0
|
0
|
37
|
308
|
135
|
0
|
10 517
|
|
| Total Equity |
422
N/A
|
6 576
+1 458%
|
7 002
+6%
|
38 498
+450%
|
44 159
+15%
|
43 382
-2%
|
43 200
0%
|
|
| Total Liabilities & Equity |
12 915
N/A
|
23 251
+80%
|
25 245
+9%
|
45 823
+82%
|
45 414
-1%
|
43 986
-3%
|
44 347
+1%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
4
|
4
|
5
|
29
|
29
|
29
|
29
|
|
| Preferred Shares Outstanding |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|